← All trials
NCT04808037
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 22, 2021
- Primary completion
- Jul 22, 2021
- Completion date
- Feb 22, 2027
- First posted
- Mar 19, 2021
- Last posted
- Mar 19, 2021
- Enrollment
- 66
- Arms / groups
- 5 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Hellenic Society of HematologyLead sponsor
- GlaxoSmithKlineCollaborator
- National Kapodistrian University of AthensOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.